ARTICLE | Company News
Organon exercises Ampakines option
January 30, 2001 8:00 AM UTC
Under a 1999 agreement, NV Organon (Oss, the Netherlands) exercised its option to license Cortex's Ampakine compounds that modulate the activity of the AMPA neurotransmitter receptor for use in the fi...